Chapter 1. Research Objective
1.1 Objective, Definition & Scope
1.2 Methodology
1.2.1 Primary Research
1.2.2 Secondary Research
1.2.3 Market Forecast - Estimation & Approach
1.2.4 Assumptions & Assessments
1.3 Insights and Growth - Relevancy Mapping
1.3.1 FABRIC Platform
1.4 Data mining & efficiency
Chapter 2. Executive Summary
2.1 Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Overview
2.2 Interconnectivity & Related markets
2.3 Ecosystem Map
2.4 Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Business Segmentation
2.5 Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Geographic Segmentation
2.6 Competition Outlook
2.7 Key Statistics
Chapter 3. Strategic Analysis
3.1 Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Revenue Opportunities
3.2 Cost Optimization
3.3 Covid19 aftermath - Analyst view
3.4 Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Digital Transformation
Chapter 4. Market Dynamics
4.1 DROC
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PEST Analysis
4.2.1 Political
4.2.2 Economic
4.2.3 Social
4.2.4 Technological
4.3 Market Impacting Trends
4.3.1 Positive Impact Trends
4.3.2 Adverse Impact Trends
4.4 Porter's 5-force Analysis
4.5 Market News - By Segments
4.5.1 Organic News
4.5.2 Inorganic News
Chapter 5. Market Segmentation
The Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market has been analysed to include the below segmentation:
BY SERVICE TYPE • CMO SEGMENT
• Active Pharmaceutical Ingredient (API) Manufacturing
• Finished Dosage Formulation (FDF) Development and Manufacturing
• Secondary Packaging
BY RESEARCH PHASE
Chapter 5A. Regional Segmentation
The Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market has been analysed by studying the following regions:
North America
• BY SERVICE TYPE • CMO SEGMENT
• BY RESEARCH PHASE
Europe
• BY SERVICE TYPE • CMO SEGMENT
• BY RESEARCH PHASE
APAC
• BY SERVICE TYPE • CMO SEGMENT
• BY RESEARCH PHASE
LatAm
• BY SERVICE TYPE • CMO SEGMENT
• BY RESEARCH PHASE
MEA
• BY SERVICE TYPE • CMO SEGMENT
• BY RESEARCH PHASE
**The Regions are further studied to analyse the major countries within the respective regions. The coverage of the country level data is dynamic and is updated regularly based on the market movements. Normally, the countries covered in the report include:
• North America - United States, Canada, Mexico;
• Europe - United Kingdom, France, Italy, Germany, Spain, Rest of Europe;
• Asia Pacific - China, India, Japan, South Korea, Rest of APAC;
• Middle East & Africa - South Africa, GCC Countries, Rest of MEA;
• Latin America - Brazil, Argentina, Rest of LatAm;
Chapter 6. Market Use case studies
Chapter 7. KOL Recommendations
Chapter 8. Investment Landscape
8.1 Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Investment Analysis
8.2 Market M&A
8.3 Market Fund Raise & Other activity
Chapter 9. Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market - Competitive Intelligence
9.1 Company Positioning Analysis
9.1.1 Positioning - By Revenue
9.1.2 Positioning - By Business Score
9.1.3 Legacy Positioning
9.2 Competitive Strategy Analysis
9.2.1 Organic Strategies
9.2.2 Inorganic Strategies
Chapter 10. Key Company Profiles
*The Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Report profiles companies based on the material impact they have on the market ecosystem. These are hence, to be read as 'Key Players' and not necessarily 'Market Leaders'.
Companies are typically profiled to include:
10.x.1 Company Fundamentals
10.x.2 Performance Overview
10.x.3 Product Overview
10.x.4 Recent Developments
Key Companies profiled in this report include:
• Catalent Inc.
• Recipharm AB
• Jubilant Life Sciences Ltd
• Patheon Inc.
• Boehringer Ingelheim Group
• Pfizer CentreSource
• Aenova Holding GmbH
• Famar SA
• Baxter Biopharma Solutions
• Lonza Group
• CMIC Holdings Co. Ltd
• Covance Inc.
• Syneos Health Inc.
• LSK Global Pharma Service Co. Ltd
• Novotech Pty Ltd
• PAREXEL International Corporation
• Pharmaceutical Product Development LLC
• PRA Health Sciences Inc.
• Quanticate Ltd
• IQVIA Holdings Inc.
• SGS Life Science Services SA
• Hangzhou Tigermed Consulting Co. Ltd
• Samsung Bioepis Co. Ltd
• WuXi AppTec Inc.
• Sagimet Biosciences (3V Biosciences Inc.)
Chapter 11. Appendix
11.1 About AllTheResearch (ATR)
11.2 ATR Services
11.3 Author details
11.4 Terms & Conditions
11.5 Contact us
Log in / Register
